Justice GCC
ar ع
  • Home
  • Legislation
  • Courts
  • Law Firms
  • Deals
Reading: UAE Regulator First to Clear Ultomiris for Proteinuria Reduction in IgA Nephropathy
Share
Justice GCCJustice GCC
Font ResizerAa
  • Legislation
  • Courts
  • Law Firms
  • Deals
Search
  • Home
  • Legislation
  • Courts
  • Law Firms
  • Deals
  • About
  • Corrections
  • Editorial Policy
  • Contact
Justice GCC > Legislation > UAE Regulator First to Clear Ultomiris for Proteinuria Reduction in IgA Nephropathy
Legislation

UAE Regulator First to Clear Ultomiris for Proteinuria Reduction in IgA Nephropathy

NewsDesk
Last updated: November 11, 2026 12:00 am
NewsDesk
Share
UAE first to approve Ultomiris for IgA nephropathy | AI-Generated Image
SHARE

The Emirates Drug Establishment granted conditional approval for a new indication of AstraZeneca’s Ultomiris to reduce proteinuria in adults with primary immunoglobulin A nephropathy who are at risk of disease progression. This decision positions the UAE as the first country to authorise the treatment for that use. Ultomiris has been registered in the UAE since 2022 for several rare diseases, the establishment reported.

Primary immunoglobulin A nephropathy is the most common immune-mediated glomerular disease worldwide. A review published in JAMA Network estimated that the condition affects between 198,887 and 208,184 persons in the United States alone. Up to 50 percent of patients may develop kidney failure within 10 to 20 years of diagnosis, according to multiple clinical studies.

Elevated protein levels in urine represent a key marker of disease advancement, prompting updated clinical guidelines that target reduction below 0.5 grams per day. The conditional approval for Ultomiris addresses this need through complement inhibition to limit further kidney damage. Dr Ruqaya Aqeel Al Bastaki, acting executive director of the medical products regulation sector at the EDE, said the framework relies on rigorous scientific assessment while maintaining the highest standards of safety, quality and efficacy.

Sameh El Fangary, Gulf Cluster President at AstraZeneca, described the approval as an important step toward expanding treatment options for eligible patients. In comments carried by the EDE, he added that the company looks forward to continued collaboration with UAE partners to improve access, treatment outcomes and quality of care. The move supports the strategic priorities of the We the UAE 2031 vision in strengthening healthcare and pharmaceutical innovation.

The EDE’s action underscores its role in accelerating availability of emerging therapies based on scientific developments. Primary IgA nephropathy arises from immune protein deposits in kidney tissue that trigger inflammation and gradual functional decline, the establishment explained. Incidence of the condition peaks in younger adults and is highest in East Asia, a Merck Manual professional edition overview found.

Ultomiris is administered intravenously, with the new indication limited to those meeting progression risk criteria. The approval builds on the medicine’s prior use in other complement-mediated disorders. This development may influence regulatory reviews in other markets for similar kidney disease applications.

Share This Article
Email Copy Link Print
ByNewsDesk
Justice GCC NewsDesk is the desk responsible for Justice GCC's daily news coverage, monitoring and reporting developments across the Gulf from official sources, including national news agencies and government communications. Its focus is accurate, timely and factual coverage of the region.
Previous Article UAE Workers Qualify for ILOE Payouts Up to AED 20,000 Monthly After Job Loss
Next Article Qatar Shura Council Sends Technical Professions Regulation Bill to Review Committee

Popular Posts

Saudi Court Sentences Kenyan Migrant Worker to 100 Lashes for Extramarital Birth

A Saudi court sentenced Kenyan domestic worker Esther Wanja Muthoni to 100 lashes after she gave birth outside marriage in…

By
NewsDesk
3 Min Read
Emirates Drug Establishment First to Approve Ultomiris for Proteinuria in IgA Nephropathy

The Emirates Drug Establishment granted conditional approval on November 10, 2026 for…

5 Min Read
Baker McKenzie Recruits Data Protection Expert Kelly Hagedorn in London Lateral Move

Baker McKenzie announced the appointment of Kelly Hagedorn as a cybersecurity and…

3 Min Read

More News

Qatar Denounces Iranian Strikes on Kuwait and Bahrain as Breaches of Sovereignty

Qatar's Ministry of Foreign Affairs condemned renewed Iranian attacks on…

November 18, 2026

VAT Group Closes Atonarp Acquisition Financed by CHF 110 Million Bilateral Loan

VAT Group completed the acquisition of…

November 18, 2026

Natroshvili Expands Business Portfolio With UAE Legal Advisory Launch

David Natroshvili, ranked the most influential…

November 17, 2026

Iran Condemns Bahrain’s Life Sentences for Shia Clerics as Rights Abuse

Iran's Foreign Ministry on November 17,…

November 17, 2026

Bahraini Court Sentences 64 to Life in Prison Over Alleged Iran Links

A Bahraini court on November 16…

November 17, 2026

Recommended for You

Legislation

UAE Cabinet Prohibits Social Media Use for Children Under 15

The UAE cabinet approved Resolution No. 106 of 2026 on June 18 banning children under 15 from creating or using…

4 Min Read
Legislation

Saudi Arabia Enforces New Regulation to Phase Out Manual Car Washing at Fuel Stations

Saudi Arabia's municipalities have begun enforcing a new regulation from the Ministry of Energy that will ban manual car washing…

2 Min Read
Legislation

Kuwait Enacts Decree-Law Overhauling Arbitration Rules for Civil and Commercial Cases

On October 18, 2026, Kuwait published Decree-Law No. 120 of 2026 in the official gazette after the Amir issued the…

4 Min Read
Legislation

UAE to Enforce Nine-Hour Daily Driving Limit for All Motorists from 2027

The UAE will prohibit all drivers from spending more than nine hours behind the wheel in any 24-hour period starting…

3 Min Read

Categories

  • Legislation
  • Courts
  • Law Firms
  • Deals

Quick Links

  • About
  • Corrections
  • Editorial Policy
  • Contact
Justice GCC
© 2026 Justice GCC. Published by Peninsula News Group LLC. All rights reserved.
  • Privacy Policy
  • Terms of Use
  • Contact
Welcome to Foxiz

Sign in to your account

Username or Email Address
Password

Lost your password?